Patents by Inventor Jean-Marc Busnel

Jean-Marc Busnel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230408492
    Abstract: This invention provides methods to evaluate therapeutic efficacy of therapeutic monoclonal antibodies.
    Type: Application
    Filed: May 26, 2023
    Publication date: December 21, 2023
    Inventors: Jean-Marc Busnel, Tewfik Miloud
  • Patent number: 11698367
    Abstract: This invention provides methods to evaluate therapeutic efficacy of therapeutic monoclonal antibodies.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: July 11, 2023
    Assignee: Beckman Coulter, Inc.
    Inventors: Jean-Marc Busnel, Tewfik Miloud
  • Patent number: 11666917
    Abstract: This disclosure is directed to methods and devices (300) associated with Point of Care medical testing and diagnostics. More specifically, methods and devices are described which provide a quick and streamlined way to prepare blood samples for analysis using flow cytometers, microscopes, and other analysis platforms. The benefits include a reduction in the time, resources, and expertise needed for preparing those blood samples without compromising the accuracy and efficacy of diagnosing diseases or identifying specific particulates from those blood samples.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: June 6, 2023
    Assignee: Beckman Coulter, Inc.
    Inventors: Fabrice Malergue, Jean-Marc Busnel
  • Publication number: 20210069703
    Abstract: This disclosure is directed to methods and devices (300) associated with Point of Care medical testing and diagnostics. More specifically, methods and devices are described which provide a quick and streamlined way to prepare blood samples for analysis using flow cytometers, microscopes, and other analysis platforms. The benefits include a reduction in the time, resources, and expertise needed for preparing those blood samples without compromising the accuracy and efficacy of diagnosing diseases or identifying specific particulates from those blood samples.
    Type: Application
    Filed: August 31, 2018
    Publication date: March 11, 2021
    Inventors: Fabrice Malergue, Jean-Marc Busnel
  • Publication number: 20200209222
    Abstract: This invention provides methods to evaluate therapeutic efficacy of therapeutic monoclonal antibodies.
    Type: Application
    Filed: September 17, 2018
    Publication date: July 2, 2020
    Inventors: Jean-Marc Busnel, Tewfik Miloud